Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Understanding sex and gender differences can improve personalized dermatology care.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Amygdalin in Persicae Semen may help treat hair loss by promoting hair growth and regulating key pathways.

Australia needs better dermatological guidelines for gender-diverse patients.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender and social factors, not just biology, affect COVID-19 death rates.

Few dermatology programs mention gender-affirming care, highlighting a need for better training and visibility.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Transgender and gender-diverse teens need specialized skin and mental health care.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.